LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 232

Search options

  1. Article ; Online: Cancer in myotonic dystrophy: A new discovery in an old disease.

    Gadalla, Shahinaz M / Greene, Mark H

    Muscle & nerve

    2023  Volume 68, Issue 2, Page(s) 101–102

    MeSH term(s) Humans ; Myotonic Dystrophy/complications ; Neoplasms
    Language English
    Publishing date 2023-05-24
    Publishing country United States
    Document type Editorial ; Research Support, N.I.H., Intramural ; Comment
    ZDB-ID 438353-9
    ISSN 1097-4598 ; 0148-639X
    ISSN (online) 1097-4598
    ISSN 0148-639X
    DOI 10.1002/mus.27844
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Familial TGCT: polygenic aetiology advanced.

    Greene, Mark H / Pfeiffer, Ruth M

    Nature reviews. Urology

    2018  Volume 15, Issue 11, Page(s) 665–666

    Language English
    Publishing date 2018-09-24
    Publishing country England
    Document type Journal Article
    ZDB-ID 2493737-X
    ISSN 1759-4820 ; 1759-4812
    ISSN (online) 1759-4820
    ISSN 1759-4812
    DOI 10.1038/s41585-018-0093-y
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Testing Positive on a Multigene Panel Does Not Suffice to Determine Disease Risks.

    Katki, Hormuzd A / Greene, Mark H / Achatz, Maria Isabel

    Journal of the National Cancer Institute

    2018  Volume 110, Issue 8, Page(s) 797–798

    MeSH term(s) Genetic Testing ; Mutation ; Phenotype
    Language English
    Publishing date 2018-03-12
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Intramural ; Comment
    ZDB-ID 2992-0
    ISSN 1460-2105 ; 0027-8874 ; 0198-0157
    ISSN (online) 1460-2105
    ISSN 0027-8874 ; 0198-0157
    DOI 10.1093/jnci/djy008
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: The fallopian tube: from back stage to center stage.

    Greene, Mark H / Mai, Phuong L

    Cancer prevention research (Philadelphia, Pa.)

    2015  Volume 8, Issue 5, Page(s) 339–341

    Abstract: The recognition that a significant fraction of what historically has been classified as ovarian cancer is, in fact, a malignancy that arises in the fallopian tube mucosa comprises a paradigm shift in our understanding of these neoplasms. New etiologic ... ...

    Abstract The recognition that a significant fraction of what historically has been classified as ovarian cancer is, in fact, a malignancy that arises in the fallopian tube mucosa comprises a paradigm shift in our understanding of these neoplasms. New etiologic and management opportunities have been created by this insight, both for women at increased genetic risk of ovarian cancer by virtue of being BRCA1/2 mutation carriers and, perhaps, for women in the general population as well.
    MeSH term(s) Female ; Humans ; Neoplasms, Glandular and Epithelial/prevention & control ; Ovarian Neoplasms/prevention & control ; Prophylactic Surgical Procedures ; Salpingectomy/statistics & numerical data
    Language English
    Publishing date 2015-03-23
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Intramural ; Comment
    ZDB-ID 2434717-6
    ISSN 1940-6215 ; 1940-6207
    ISSN (online) 1940-6215
    ISSN 1940-6207
    DOI 10.1158/1940-6207.CAPR-15-0072
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Embodied risk for families with Li-Fraumeni syndrome: Like electricity through my body.

    Werner-Lin, Allison / Forbes Shepherd, Rowan / Young, Jennifer L / Wilsnack, Catherine / Merrill, Shana L / Greene, Mark H / Khincha, Payal P

    Social science & medicine (1982)

    2022  Volume 301, Page(s) 114905

    Abstract: Introduction: Experiences of illness change the physical body and embodiments, or the ways in which the world and the self are known through the body. When illness is anticipated, such as with inherited cancer predisposition syndromes, risk becomes ... ...

    Abstract Introduction: Experiences of illness change the physical body and embodiments, or the ways in which the world and the self are known through the body. When illness is anticipated, such as with inherited cancer predisposition syndromes, risk becomes embodied and shared in family groups. Embodied risk is experienced whether or not symptoms have manifested. To examine how individuals and families with genetic risk experience the world and understand their disease through their bodies, we employ Li-Fraumeni syndrome (LFS) as an exemplar. LFS is a rare, genetic, cancer predisposition syndrome with nearly 100% lifetime cancer risk starting from birth, limited opportunities for prevention, rigorous screening protocols, and early mortality.
    Methods: Forty-five families, including 117 individuals aged 13-81 years, enrolled in the National Cancer Insitute's LFS study (NCT01443468) completed 66 open-ended interviews regarding LFS experiences. An interdisciplinary team used modified grounded theory to explore physical aspects of living with LFS in psychosocial contexts.
    Findings: The physicality of living with LFS included constant monitoring of LFS bodies across the family to identify physical change that might indicate carcinogenesis. Cancer screening, risk reduction, and treatment acted as dually protective and invasive, and as an unavoidable features of LFS. Connections between family members with similar embodiments normalized aesthetic changes and supported coping with visible markers of difference. In some circumstances, participants objectified the body to preserve the self and important relationships. In others, intense pain or loss created thresholds beyond which the self could no longer be separated from the body to support coping.
    Discussion: This paper focuses on Li-Fraumeni syndrome, a familial condition with a well-established genetic identity in which the body-self is experienced in relation to important others, to medical imaging, and to historical experiences with cancer. We expand on theories of embodied risk and inter-embodiment to describe experiences across disease trajectories, with attention to division and union between body, self, and other.
    MeSH term(s) Early Detection of Cancer ; Electricity ; Family ; Genetic Predisposition to Disease ; Humans ; Li-Fraumeni Syndrome/complications ; Li-Fraumeni Syndrome/diagnosis ; Li-Fraumeni Syndrome/genetics
    Language English
    Publishing date 2022-03-17
    Publishing country England
    Document type Journal Article ; Research Support, N.I.H., Intramural
    ZDB-ID 4766-1
    ISSN 1873-5347 ; 0037-7856 ; 0277-9536
    ISSN (online) 1873-5347
    ISSN 0037-7856 ; 0277-9536
    DOI 10.1016/j.socscimed.2022.114905
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article: Anticipatory loss and early mastectomy for young female BRCA1/2 mutation carriers.

    Hoskins, Lindsey M / Greene, Mark H

    Qualitative health research

    2012  Volume 22, Issue 12, Page(s) 1633–1646

    Abstract: Young women who carry BRCA1/2 mutations face difficult decisions in managing their hereditary breast/ovarian cancer risk. Through this National Cancer Institute study, we sought to understand the process by which some young women choose risk-reducing ... ...

    Abstract Young women who carry BRCA1/2 mutations face difficult decisions in managing their hereditary breast/ovarian cancer risk. Through this National Cancer Institute study, we sought to understand the process by which some young women choose risk-reducing bilateral mastectomy (RRBM) instead of alternative risk-management options. Data indicate that electing to undergo RRBM, although difficult, is experienced as a way to sidestep potentially devastating outcomes, such as stressful and costly high-risk screening, chemotherapy or radiation, or putting loved ones through the challenges of a cancer diagnosis. The decision to pursue RRBM is often the product of screening fatigue, encouragement from loved ones, and/or a sense of urgency to put one's high-risk period behind one. By understanding how young carriers make decisions about surgical risk reduction, providers can better guide, counsel, and support patients in the important tasks surrounding this life-changing medical decision, thereby helping to increase the duration and quality of their lives.
    MeSH term(s) Adult ; Breast Neoplasms/genetics ; Breast Neoplasms/prevention & control ; Breast Neoplasms/psychology ; Decision Making ; Female ; Genes, BRCA1 ; Genes, BRCA2 ; Genetic Predisposition to Disease ; Humans ; Interviews as Topic ; Mastectomy ; Mutation ; Risk Reduction Behavior
    Language English
    Publishing date 2012-12
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, N.I.H., Intramural
    ZDB-ID 1275716-0
    ISSN 1552-7557 ; 1049-7323
    ISSN (online) 1552-7557
    ISSN 1049-7323
    DOI 10.1177/1049732312458182
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Waiting and "weighted down": the challenge of anticipatory loss for individuals and families with Li-Fraumeni Syndrome.

    Werner-Lin, Allison / Young, Jennifer L / Wilsnack, Catherine / Merrill, Shana L / Groner, Victoria / Greene, Mark H / Khincha, Payal P

    Familial cancer

    2020  Volume 19, Issue 3, Page(s) 259–268

    Abstract: Li-Fraumeni Syndrome (LFS) is characterized by risk of multiple primary malignancies in diverse sites, pediatric onset, near complete penetrance by age 70 years, limited options for prevention, and substantial uncertainty regarding disease manifestation ... ...

    Abstract Li-Fraumeni Syndrome (LFS) is characterized by risk of multiple primary malignancies in diverse sites, pediatric onset, near complete penetrance by age 70 years, limited options for prevention, and substantial uncertainty regarding disease manifestation and prognosis. Forty-five families, including 117 individuals aged 13-81 years, enrolled in the US National Cancer Institute's Li-Fraumeni Syndrome Study completed 66 interviews regarding their LFS experiences. An interdisciplinary team used modified grounded theory to examine family distress regarding expectations of loss and change due to likely cancer diagnoses, and the consequences of this likelihood across physical, social, and emotional domains. Disease-free periods were characterized by fearful anticipation of diagnosis or recurrence, uncertainty regarding post-treatment quality of life, and planning for shifts in family dynamics to enable caregiving. The chronicity of waiting for these changes incited dread and inhibited effective coping with the pragmatic, emotional, and existential challenges of the syndrome. Consequently, families reported high burden on roles and resources and limited guidance to prepare for, or achieve resolution with, grief. Anticipatory loss, the experience of bereavement prior to an expected change, distinguishes hereditary cancer risk from a sporadic diagnosis. Such grief is often incomplete in impact or meaning, subjected to rapid or profound change as conditions worsen, and poorly understood. In this study, losses were compounded by profound uncertainty, a chronic feature of LFS, which compromised mourning. Long-term engagement of mental health providers with bereavement training, in partnership with genetics providers, can provide invaluable educational and psychological support to families as they navigate these implacable challenges.
    MeSH term(s) Adolescent ; Adult ; Aged ; Aged, 80 and over ; Anticipation, Psychological ; Bereavement ; Child ; Child, Preschool ; Data Analysis ; Early Detection of Cancer ; Family ; Female ; Genes, p53 ; Genetic Counseling ; Grief ; Grounded Theory ; Hope ; Humans ; Li-Fraumeni Syndrome/diagnosis ; Li-Fraumeni Syndrome/genetics ; Li-Fraumeni Syndrome/psychology ; Male ; Middle Aged ; Mutation ; Prognosis ; Psychological Distress ; Psychosocial Support Systems ; Qualitative Research ; Quality of Life ; Uncertainty ; Young Adult
    Language English
    Publishing date 2020-03-27
    Publishing country Netherlands
    Document type Journal Article ; Research Support, N.I.H., Extramural
    ZDB-ID 1502496-9
    ISSN 1573-7292 ; 1389-9600
    ISSN (online) 1573-7292
    ISSN 1389-9600
    DOI 10.1007/s10689-020-00173-6
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: A major step forward for BRCA1/2-related cancer risk management.

    Mai, Phuong L / Loud, Jennifer T / Greene, Mark H

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology

    2014  Volume 32, Issue 15, Page(s) 1531–1533

    MeSH term(s) BRCA1 Protein/genetics ; BRCA2 Protein/genetics ; Fallopian Tube Neoplasms ; Female ; Humans ; Incidence ; Mutation ; Ovarian Neoplasms ; Ovariectomy/mortality
    Chemical Substances BRCA1 Protein ; BRCA1 protein, human ; BRCA2 Protein ; BRCA2 protein, human
    Language English
    Publishing date 2014-05-20
    Publishing country United States
    Document type Comment ; Editorial
    ZDB-ID 604914-x
    ISSN 1527-7755 ; 0732-183X
    ISSN (online) 1527-7755
    ISSN 0732-183X
    DOI 10.1200/JCO.2013.54.8925
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: In their own words: treating very young BRCA1/2 mutation-positive women with care and caution.

    Hoskins, Lindsey M / Werner-Lin, Allison / Greene, Mark H

    PloS one

    2014  Volume 9, Issue 2, Page(s) e87696

    Abstract: Purpose: Young women who have been identified as carrying a deleterious mutation in BRCA1 or BRCA2 face a unique set of challenges related to managing cancer risk during a demographically-dense stage of life. They may struggle with decision-making in ... ...

    Abstract Purpose: Young women who have been identified as carrying a deleterious mutation in BRCA1 or BRCA2 face a unique set of challenges related to managing cancer risk during a demographically-dense stage of life. They may struggle with decision-making in the absence of clear age-specific guidelines for medical management and because they have not yet fully developed the capacity to make life-altering decisions confidently. This study sought a patient-centered perspective on the dilemmas faced by 18-24 year olds who completed BRCA1/2 gene mutation testing prior to their 25(th) birthdays.
    Patients and method: This study integrated qualitative data from three independent investigations of BRCA1/2-positive women recruited through cancer risk clinics, hospital-based research centers, and online organizations. All 32 participants were women aged 21-25 who tested positive for a BRCA1/2 gene mutation between 2 and 60 months prior to data collection. Investigators used techniques of grounded theory and interpretive description to conduct both within and cross-study analysis.
    Results: Participants expressed needs for (1) greater clarity in recommendations for screening and prevention before age 25, especially with consideration of early and regular exposure to radiation associated with mammography or to hormones used in birth control, and (2) ongoing contact with providers to discuss risk management protocols as they become available.
    Conclusions: Health care needs during the young adult years evolve with the cognitive capacity to address abrupt and pressing change. Specific needs of women in this population include a desire to balance autonomous decision-making with supportive guidance, a need for clear, accurate and consistent medical recommendations. Optimally, these women are best cared for by a team of genetically-oriented providers as part of a sustained program of ongoing support, rather than seen in an episodic, crisis-driven fashion. A discussion of insurance issues and provider-patient cultural differences is presented.
    MeSH term(s) Adolescent ; Adult ; BRCA1 Protein/genetics ; BRCA2 Protein/genetics ; Breast Neoplasms/genetics ; Decision Making ; Delivery of Health Care ; Female ; Humans ; Mutation ; Young Adult
    Chemical Substances BRCA1 Protein ; BRCA1 protein, human ; BRCA2 Protein ; BRCA2 protein, human
    Language English
    Publishing date 2014-02-28
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Intramural
    ZDB-ID 2267670-3
    ISSN 1932-6203 ; 1932-6203
    ISSN (online) 1932-6203
    ISSN 1932-6203
    DOI 10.1371/journal.pone.0087696
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Reply to m.j. Mourits et Al.

    Sherman, Mark E / Piedmonte, Marion / Mai, Phuong L / Greene, Mark H

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology

    2015  Volume 33, Issue 13, Page(s) 1515

    MeSH term(s) Breast Neoplasms/genetics ; Breast Neoplasms/pathology ; Fallopian Tube Neoplasms/pathology ; Female ; Humans ; Neoplasms, Unknown Primary/pathology ; Ovarian Neoplasms/pathology
    Language English
    Publishing date 2015-05-01
    Publishing country United States
    Document type Comment ; Letter ; Research Support, Non-U.S. Gov't
    ZDB-ID 604914-x
    ISSN 1527-7755 ; 0732-183X
    ISSN (online) 1527-7755
    ISSN 0732-183X
    DOI 10.1200/JCO.2014.60.2482
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top